Page 369 - Biến Chứng Bệnh Đái Tháo Đường
P. 369
8. Karam J. H.
Diabetes Mellitus. Current Medical Diagnosis &
treatment. Appletoon & large, 1992: 900-929.
9. Kare S. L., Lam . : 1
^ • * •
Dyslipitaemia and prothrombotic tendency in type II
diabetes. ’
• • g • • • *
Diabetes in the new millenium 1999; 33r 327-334.
10. Koya H., Jirousek M. R., Wei Y,L., et aL
Chuaracterizaion of prtein kinase C P isoform activation
on the gene expression of transforming groowth factor - p,
extracelleulor matrix component, and prostanoids in the
glomeruli of diabetic rats.
J Clin Invert 1977; 10: 115-126.
11. Lewis E. J., Hunsicker L.G., Bain R.P.
The effect of angiotensin - converting - enzyme inhibition
on diabetic nephropathy. N Engl. J Med. 1993; 329: 1456 -
•• • •• •
1462.
•
• • • * • ••
12. Mauer S. M., Steffes M. W., Ellis E.N., et al.
Structural - function relationships in diabetic nephropathy
N Enghll. J Med. 1993; 329: 1143-1155.
13. Shoji T., Nishizawa Y., Toyokawa A., et al.
• . •
Secreased albuminuria by pravastatin in hyperlipitaemic
diabetic.
Nephron 1991; 59: 664-665.
14. American Diabetes Association: Treatment of
hypertension in adult with diabetes. Diabetes care 26.
580-582. 2003.
15. American Diabetes Association: Diabetes Nephropathy.
Supp 1 S94-S99. 2003.
373
